|
CUREVAC N.V. (CVAC) DCF Valoración
DE | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
CureVac N.V. (CVAC) Bundle
¿Busca determinar el valor intrínseco de CUREVAC N.V.? Nuestra calculadora CVAC DCF integra datos del mundo real con características integrales de personalización, lo que le permite refinar sus pronósticos y tomar decisiones de inversión más informadas.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 18.2 | 51.0 | 107.4 | 70.3 | 56.0 | 76.4 | 104.1 | 141.9 | 193.4 | 263.6 |
| Revenue Growth, % | 0 | 180.78 | 110.61 | -34.54 | -20.26 | 36.3 | 36.3 | 36.3 | 36.3 | 36.3 |
| EBITDA | -95.4 | -128.3 | -402.9 | -218.3 | -244.0 | -76.4 | -104.1 | -141.9 | -193.4 | -263.6 |
| EBITDA, % | -525.38 | -251.73 | -375.27 | -310.57 | -435.45 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | 5.0 | 14.2 | 37.4 | 27.3 | 24.4 | 26.3 | 35.9 | 48.9 | 66.7 | 90.8 |
| Depreciation, % | 27.34 | 27.83 | 34.84 | 38.8 | 43.5 | 34.46 | 34.46 | 34.46 | 34.46 | 34.46 |
| EBIT | -100.3 | -142.5 | -440.3 | -245.5 | -268.4 | -76.4 | -104.1 | -141.9 | -193.4 | -263.6 |
| EBIT, % | -552.72 | -279.56 | -410.1 | -349.37 | -478.95 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 33.5 | 1,381.4 | 850.7 | 521.5 | 422.3 | 76.4 | 104.1 | 141.9 | 193.4 | 263.6 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 17.9 | 1.9 | 56.0 | 9.4 | 41.2 | 36.9 | 50.2 | 68.5 | 93.3 | 127.2 |
| Account Receivables, % | 98.49 | 3.73 | 52.18 | 13.35 | 73.5 | 48.25 | 48.25 | 48.25 | 48.25 | 48.25 |
| Inventories | 6.5 | 15.1 | 58.5 | 25.0 | 25.9 | 30.8 | 42.0 | 57.2 | 78.0 | 106.3 |
| Inventories, % | 35.58 | 29.72 | 54.53 | 35.58 | 46.13 | 40.31 | 40.31 | 40.31 | 40.31 | 40.31 |
| Accounts Payable | 5.6 | 18.4 | 127.5 | 71.1 | 48.3 | 53.9 | 73.5 | 100.1 | 136.5 | 186.1 |
| Accounts Payable, % | 30.61 | 36.04 | 118.71 | 101.23 | 86.25 | 70.58 | 70.58 | 70.58 | 70.58 | 70.58 |
| Capital Expenditure | -12.7 | -49.4 | -133.3 | -97.2 | -57.5 | -71.3 | -97.2 | -132.5 | -180.6 | -246.2 |
| Capital Expenditure, % | -70.19 | -96.83 | -124.19 | -138.27 | -102.68 | -93.4 | -93.4 | -93.4 | -93.4 | -93.4 |
| Tax Rate, % | -0.07616293 | -0.07616293 | -0.07616293 | -0.07616293 | -0.07616293 | -0.07616293 | -0.07616293 | -0.07616293 | -0.07616293 | -0.07616293 |
| EBITAT | -100.1 | -141.7 | -439.4 | -245.4 | -268.6 | -76.2 | -103.9 | -141.6 | -193.0 | -263.1 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -126.7 | -156.8 | -523.8 | -291.5 | -357.2 | -116.3 | -170.2 | -232.0 | -316.3 | -431.1 |
| WACC, % | 16.14 | 16.14 | 16.14 | 16.14 | 16.14 | 16.14 | 16.14 | 16.14 | 16.14 | 16.14 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -752.3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -440 | |||||||||
| Terminal Value | -3,110 | |||||||||
| Present Terminal Value | -1,472 | |||||||||
| Enterprise Value | -2,224 | |||||||||
| Net Debt | -376 | |||||||||
| Equity Value | -1,848 | |||||||||
| Diluted Shares Outstanding, MM | 221 | |||||||||
| Equity Value Per Share | -8.37 |
What You Will Get
- Editable Forecast Inputs: Easily modify key assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: CureVac N.V.’s (CVAC) financial data pre-loaded to facilitate your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A sleek Excel model tailored to meet your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, validating strategies, and enhancing efficiency.
Key Features
- Comprehensive DCF Calculator: Provides detailed unlevered and levered DCF valuation models tailored for CureVac N.V. (CVAC).
- WACC Calculator: Features a pre-built Weighted Average Cost of Capital sheet with adjustable inputs specific to CVAC.
- Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates to match CureVac's strategies.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios relevant to CureVac N.V. (CVAC).
- Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for straightforward analysis.
How It Works
- Download the Template: Gain immediate access to the Excel-based CVAC DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and more.
- Instant Calculations: The model automatically recalculates CureVac’s intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential valuation shifts.
- Analyze and Decide: Utilize the results to inform your investment or financial decisions.
Why Choose This Calculator for CureVac N.V. (CVAC)?
- Designed for Experts: A sophisticated tool tailored for researchers, investors, and financial analysts.
- Comprehensive Data: CureVac’s historical and projected financials are preloaded for precision.
- Flexible Scenario Analysis: Effortlessly test various forecasts and assumptions.
- Insightful Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step guidance ensures a smooth experience.
Who Should Use CureVac N.V. (CVAC)?
- Biotechnology Students: Explore cutting-edge mRNA technology and its applications in real-world scenarios.
- Researchers: Utilize CureVac's innovative models in your studies or clinical trials.
- Investors: Evaluate your investment strategies and analyze the market performance of CureVac N.V. (CVAC).
- Healthcare Analysts: Enhance your analysis with a tailored financial model specific to biotech firms.
- Pharmaceutical Entrepreneurs: Understand how established biotech companies like CureVac N.V. (CVAC) navigate the industry.
What the Template Contains
- Historical Data: Includes CureVac N.V.'s (CVAC) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate CureVac N.V.'s (CVAC) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of CureVac N.V.'s (CVAC) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.